Sapient Capital »

Biogen Idec shares owned by Sapient Capital

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Sapient Capital from 13F filings

Historical chart of Sapient Capital investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Sapient Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Sapient Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $210k 1.1k 183.33

More positions owned by Sapient Capital

Eli Lilly & Co. (LLY)
Ea Series Trust Sapient Quality (SQS)
Applovin Corp Com Cl A (APP)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Vistra Energy (VST)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Costco Wholesale Corporation (COST)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Sapient Capital

Top funds holding Biogen Idec

Vanguard Group
BlackRock
PRIMECAP Management Company
Vanguard Capital Management
FMR
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
Wellington Management Company
Susquehanna International
Morgan Stanley
AQR Capital Management
Invesco
Robeco Investment Management
Barclays

View all funds holding Biogen Idec